C12N 2760/18621
Viruses as such
Official title: Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N2760/18621 (Viruses as such) appears on 16 US grants and 24 published applications in this corpus.
Search patents in C12N- Granted patents
- 16
- Published applications
- 24
- Assignees
- 17
- Inventors
- 31
- Latest grant
- 11 Jan 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 3 |
| 2004 | 2 | 2 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 2 | 1 |
| 2009 | 0 | 3 |
| 2010 | 1 | 3 |
| 2011 | 1 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 1 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 2 | 1 |
| 2018 | 1 | 2 |
| 2019 | 1 | 0 |
| 2020 | 0 | 3 |
| 2021 | 1 | 0 |
| 2022 | 1 | 0 |
| 2023 | 0 | 2 |
By publication year.
Recent patents
- Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences11 Jan 2022US 11,220,718 B2Erasmus University Medical Center Rotterdam
- Porcine parainfluenza virus type 1 isolates and immunogenic compositions therefrom25 May 2021US 11,013,796 B2Iowa State University Research Foundation, Inc.
- Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences14 May 2019US 10,287,640 B2Erasmus University Medical Center Rotterdam
- Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences17 Apr 2018US 9,944,997 B2Erasmus University Medical Center Rotterdam
- Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences5 Dec 2017US 9,834,824 B2Erasmus University Medical Center Rotterdam
- Virus stabilizer, gelatin hydrolysate for virus stabilizer, and viruscontaining composition15 Jun 2023US 2023/0183657 A1Incorporated Educational Institution Rakuno Gakuen
- Broadly protective bovine parainfluenza 3 virus and bovine viral diarrhea virus vaccine2 Feb 2023US 2023/0029979 A1Kansas State University Research Foundation
- Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences24 Dec 2020US 2020/0399718 A1Erasmus University Medical Center Rotterdam
- Novel porcine parainfluenza virus type 1 isolates and immunogenic compositions therefrom5 Mar 2020US 2020/0069789 A1Iowa State University Research Foundation, Inc.
- Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences23 Jan 2020US 2020/0024672 A1Erasmus University Medical Center Rotterdam
Most cited
By later US patents
- Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences30US 7,449,324 B2MedImmune, LLC · 2008
- Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences27US 8,841,433 B2ViroNovative BV · 2014
- Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences22US 9,567,653 B2Erasmus University Medical Center Rotterdam · 2017
- Recombinant parainfluenza virus expression systems and vaccines12US 8,084,037 B2MedImmune, LLC · 2011
- Recombinant parainfluenza virus expression systems and vaccines10US 7,238,481 B2MedImmune Vaccines, Inc. · 2007